The global market for Gamma Knife Systems is growing very fast, stimulated by a rising demand for non-invasive surgical procedures on the brain. This technology, which is known for treating brain disorders in a very precise way, has been widely accepted by health care institutions. As a result, the market for Gamma Knife Systems is experiencing rapid growth. This article gives an in-depth analysis of global current trend, the major power driving it and the prospect in future of Gamma knife system’s market.
Market Overview
gamma-knife-system-market are specialized devices which perform radiosurgery, a non-invasive procedure that treats brain tumors, arterial venous malformations (AVMs) and other neurological disorders. The system uses focused beams of gamma radiation to target and destroy diseased tissue with pinpoint accuracy and minimal damage to surrounding healthy tissue. The increasing influence of bringing into use theγ KnifePro abundant wealth and good treatment available (including brain tumors and other neurological conditions), together with a shift toward non-invasive treatment options is causing a demand of Gamma Knife Systems worldwide to grow.
Key Drivers of the Market
Several reasons explain the growth of Gamma Knife System market. One of the primary drivers is the worldwide increase in the prevalence of neurological disorders. According to the World Health Organization (WHO), these diseases are now the leading cause for disabilities and also the second largest killers worldwide. This has led to a surge in demand for advanced treatment such as Gamma Knife radiosurgery. Furthermore, modern Gamma Knife Systems are contributing significantly to market growth. These systems correctly manage patient resources, minimize treatment time and increase patient comfort. Integrating technologies of brain imaging into the Gamma Knife Systems (like magnetic resonance imaging [MRI] and computed tomography [CT]) has also made them more efficient in reaching lesions.
Market segmentation
Global Gamma Knife System market segment includes: product type, application, end-user and region. Based on product type, the company markets the Leksell Gamma Knife and the Perfexion Gamma Knife. Applications for Gamma Knife Systems include treating brain tumours, AVMs (arteriovenous malformations), trigeminal neuralgia and other neurological disorders. The end users of the system are mainly hospitals, clinics and specialized neurosurgery centers.
On the basis of geographical location, the market is divided into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. At present North America holds the largest share of the market. This is driven by the high prevalence there of neurological disorders, the advanced health care infrastructure developed in the region and the presence on its territory of key market players. However, Asia-Pacific is projected to see the highest growth rate due to increased healthcare expenditure, greater awareness about Gamma Knife radiosurgery and a huge increase in incidents involving brain disorders
Challenges and opportunities
Despite the growth of the Gamma Knife System market, it faces various challenges. The high cost of Gamma Knife Systems as well as the need for skilled professionals to operate such systems are significant obstacles to market growth, particularly in developing countries. However, investment in healthcare infrastructure has been increasing, particularly in emerging economies, and advanced medical technologies are being adopted by more people.
In addition, research and development work aimed at improving the efficiency and accessibility of Gamma Knife Systems is expected to foster further market growth. Making Gamma Knife Systems portable and affordable could open up the market still more, especially in areas that have received no benefit because of lack of resources.
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian